| abstract |
An artificial lung surfactant comprising (a) phosphatidyl choline and cardiolipin and/or phosphatidyl glycerol in addition as phospholipids, wherein the content of said phospholipids is 80 to 95 wt % of the whole composition, (b) neutral lipids, wherein the content is 5 to 20 wt % of the whole composition, and (c) fatty acids, wherein the content is 0 to 10 wt % of the whole composition, and a remedy for the respiratory distress syndrome containing said surfactant as an active principle. |